Foundation investments in preeminent cancer research and treatment can lead to improved patient care and the development of innovative therapies that save lives.
Memorial Sloan-Kettering Cancer Center, which treats more children and young adults with cancer than any other institution in the world, to construct a 45,228 square-foot pediatric care facility to provide technologically sophisticated cancer care, with an emphasis on outpatient treatment
In October 2004, Memorial Sloan-Kettering dedicated the new Claire Tow Pediatric Pavilion, a state-of-the-art facility providing an attractive and highly functional inpatient care unit with 33 beds and cribs. The Pavilion features The Claire Tow Pediatric Day Hospital, a welcoming “home-away-from-home” for pediatric patients and their families that now registers more than 150 outpatient visits per day. It brings together the latest treatments for cancer in children with a range of amenities designed to meet each child’s special needs—from a soaring, light-filled Recreation Center and a Board of Education-certified school program, to a constantly evolving roster of support services and activities.
Today, The Claire Tow Pediatric Day Hospital and The Claire Tow Pediatric Pavilion of which it is part are setting a new standard for understanding and treating pediatric cancer. Approximately 90 percent of pediatric therapy at Memorial Sloan-Kettering is delivered on an outpatient basis, yielding dramatic improvements in quality of life for children and their families during treatment. Overall, more than 70 percent of children diagnosed with cancer can be cured. Childhood leukemia has seen cure rates rise from almost zero in the 1960s to more than 80 percent today, spurred in part by pioneering discoveries at Memorial Sloan-Kettering.